Reference | Case-cohort representative | Selection of non-exposed control | Ascertainment of exposure | Outcome negative at start | Comparability by design | Comparability by analysis | Outcome assessment | Duration of follow-up | Adequacy of follow-up | Score |
---|---|---|---|---|---|---|---|---|---|---|
Panici et al., 2012 [15] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Qiu et al., 2015 [16] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Cui et al., 2016 [12] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Chen et al.,2016 [11] | √ | √ | √ | √ | × | × | √ | √ | √ | 7 |
Wu et al., 2016 [19] | √ | √ | √ | √ | × | √ | √ | √ | √ | 8 |
Duan et al., 2016 [13] | √ | √ | √ | √ | √ | √ | √ | √ | √ | 9 |
Sun et al., 2018 [17] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Xie et al., 2017 [20] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Gong et al.,, 2017 [14] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Wang et al., 2017 [18] | √ | √ | √ | √ | √ | × | √ | √ | √ | 8 |
Wei et al., 2018 [21] | √ | √ | √ | √ | × | × | √ | √ | √ | 7 |